Deutsche Bank
BBC icon

Deutsche Bank’s Virtus Biotech Clinical Trials ETF BBC Stock Holding History

Deutsche Bank’s Portfolio BBC Stock Details BBC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-224,754
Closed -$6.23M – 5132
2014
Q4 		$6.23M Buy
+224,754
New +$6.16M ﹤0.01% 1775

Other funds holding BBC

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
BAAM
Baker Avenue Asset Management San Francisco, California $5.28B AUM 39.19% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Deutsche Bank's BBC Position: Q1 2015 in Review

Deutsche Bank sold out of Virtus Biotech Clinical Trials ETF (BBC) in Q1 2015, closing a stake of 224,754 shares — an estimated $6.23M sold.

Deutsche Bank first reported a position in BBC in Q4 2014 and held it in 1 quarter. The position peaked at $6.23M in Q4 2014. 10 funds tracked by Wall St. Rank hold BBC as of Q1 2015.

  • Deutsche Bank reported no remaining Virtus Biotech Clinical Trials ETF position as of Q1 2015 after selling out during the quarter.
  • Deutsche Bank sold 224,754 Virtus Biotech Clinical Trials ETF shares in Q1 2015, an estimated $6.23M.
  • Deutsche Bank first reported a position in Virtus Biotech Clinical Trials ETF in Q4 2014 and held it in 1 quarter.
  • Deutsche Bank's Virtus Biotech Clinical Trials ETF position peaked at $6.23M in Q4 2014.
  • 10 funds tracked by Wall St. Rank held Virtus Biotech Clinical Trials ETF as of Q1 2015.

Based on Deutsche Bank's 13F filing for Q1 2015, filed 15 May 2015.